Literature DB >> 32380502

Molecular Genomic Blood Biomarkers for Neuroendocrine Tumors: The Long and Winding Road from Berzelius and Bence Jones to a Neuroendocrine Destination.

Kjell Öberg1.   

Abstract

Year:  2020        PMID： 32380502     DOI： 10.1159/000508488

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  6 in total

Review 1.  [Modern molecular and imaging diagnostics in pancreatic neuroendocrine neoplasms].

Authors:  Costanza Chiapponi; Christiane J Bruns
Journal:  Chirurgie (Heidelb)       Date:  2022-05-25

Review 2.  The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung.

Authors:  Mateusz Bilski; Paulina Mertowska; Sebastian Mertowski; Marcin Sawicki; Anna Hymos; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

Review 3.  An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Jiayun M Fang; Jay Li; Jiaqi Shi
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.374

4.  The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues.

Authors:  Roberta Elisa Rossi; Sara Massironi
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

Review 5.  Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.

Authors:  Paweł Komarnicki; Jan Musiałkiewicz; Alicja Stańska; Adam Maciejewski; Paweł Gut; George Mastorakos; Marek Ruchała
Journal:  J Clin Med       Date:  2022-09-21       Impact factor: 4.964

6.  Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2.

Authors:  Dimitrios Papantoniou; Malin Grönberg; Kalle Landerholm; Staffan Welin; Barbara Ziolkowska; Dennis Nordvall; Eva Tiensuu Janson
Journal:  Endocrine       Date:  2020-11-26       Impact factor: 3.633
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.